Left atrial appendage closure with the II generation Ultraseal device: An international registry. The LIGATE study

OBJECTIVES: To assess feasibility and safety of second‐generation left atrial appendage closure (LAAC) Ultraseal device in patients with nonvalvular atrial fibrillation (NVAF). BACKGROUND: LAAC with first‐generation Ultraseal device (Cardia, Eagan, Minnesota) has been shown to be a feasible therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pivato, Carlo A., Liccardo, Gaetano, Sanz‐Sanchez, Jorge, Pelloni, Elisa, Pujdak, Krzysztof, Xuareb, Robert G., Cruz‐Gonzalez, Ignacio, Pisano, Francesco, Scotti, Andrea, Tarantini, Giuseppe, Cook, Stephane, Regazzoli, Damiano, Reimers, Bernhard, Condorelli, Gianluigi, Bragato, Renato Maria, Stefanini, Giulio G., Pagnotta, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Valvular and Structural Heart Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796275/
https://www.ncbi.nlm.nih.gov/pubmed/35842775
http://dx.doi.org/10.1002/ccd.30336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796275/
https://www.ncbi.nlm.nih.gov/pubmed/35842775
http://dx.doi.org/10.1002/ccd.30336

Ejemplares similares